Publication
Using cancer registries to supplement clinical trial data and inform regulatory decision
dc.contributor.author | Costa, Filipa Alves da | |
dc.contributor.author | Miranda, Ana da Costa | |
dc.date.accessioned | 2021-05-25T13:35:43Z | |
dc.date.available | 2021-05-25T13:35:43Z | |
dc.date.issued | 2020-10 | |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | da Costa, FA, da Costa Miranda, A. Using cancer registries to supplement clinical trial data and inform regulatory decision. Pharmacoepidemiol Drug Saf. 2020; 29: 1319– 1321. https://doi.org/10.1002/pds.4931 | pt_PT |
dc.identifier.doi | 10.1002/pds.4931 | pt_PT |
dc.identifier.issn | 1053-8569 | |
dc.identifier.issn | 1099-1557 | |
dc.identifier.uri | http://hdl.handle.net/10400.26/36597 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.relation.publisherversion | https://doi.org/10.1002/pds.4931 | pt_PT |
dc.subject | Cancer | pt_PT |
dc.subject | Clinical trial | pt_PT |
dc.title | Using cancer registries to supplement clinical trial data and inform regulatory decision | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 1321 | pt_PT |
oaire.citation.startPage | 1319 | pt_PT |
oaire.citation.title | Pharmacoepidemiology and Drug Safety | pt_PT |
oaire.citation.volume | 29(10) | pt_PT |
rcaap.embargofct | Política de copyright do editor | pt_PT |
rcaap.rights | restrictedAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Costa and Miranda 2019_Using cancer registries to supplement clinical trial data an inform regulatory decision.pdf
- Size:
- 125.11 KB
- Format:
- Adobe Portable Document Format